Coronavirus disease (COVID-19), HIV & hepatitis C: What you need to know

In Hepatitis, HIV

March 24, 2020

1 Min Read

C

CATIE (Canada), 17 March 2020

An HIV-positive person on effective treatment is not expected to be at higher risk of becoming seriously ill with COVID-19
A person with untreated HIV or a low CD4+ cell count may be at higher risk of becoming seriously ill with COVID-19
People with HIV or hepatitis C are more likely to have other conditions that carry a greater risk of becoming seriously ill with COVID-19

2019 novel coronavirus (COVID-19) Aboriginal and Torres Strait Islander people aged care facilities antiretroviral treatment (ART) antiviral treatment asthma Australasian Society for HIV Viral Hepatitis and Sexual Health Medicine (ASHM) Australia Australian Federation of AIDS Organisations (AFAO) autoimmune diseases blood pressure blood-borne viruses (BBVs) Canada cardiovascular CD4+ count cholesterol chronic illness community pharmacies comorbidity contact COPD diabetes exposure hand hygiene health care hepatitis C (HCV) HIV (human immunodeficiency virus) homelessness hygiene infection isolation LGBTIQ+ liver lungs mask medications monitoring morbidity mortality National Association of People with HIV Australia (NAPWHA) Non-alcoholic fatty liver disease (NAFLD) nose obesity older people pandemic people living with HIV (PLHIV) People Who Inject Drugs (PWID) pets population health renal respiratory risk risk reduction severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) smoking social distancing throat transmission undetectable viral load (UVL) untreated HIV vaccine viral hepatitis viral load viral suppression viruses

Facebook Twitter Reddit

By J Pope March 24, 2020